OCS-01
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for OCS-01, covering 2022-03-15 to 2026-07-30. Get the full timeline:
Most recent: Clinical Trial Results: A Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Opthalmic Suspension Compared to Vehicle for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery [Phase 3]